Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta

Till F. M. Andlauer; Jenny Link; Dorothea Martin; Malin Ryner; Christina Hermanrud; Verena Grummel; Michael Auer; Harald Hegen; Lilian Aly; Christiane Gasperi; Benjamin Knier; Bertram Müller-Myhsok; Poul Erik Hyldgaard Jensen; Finn Sellebjerg; Ingrid Kockum; Tomas Olsson; Marc Pallardy; Sebastian Spindeldreher; Florian Deisenhammer; Anna Fogdell-Hahn; Bernhard Hemmer; on behalf of the ABIRISK consortium

doi:10.1101/2020.05.01.20086033

Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta

View ORCID ProfileTill F. M. Andlauer, View ORCID ProfileJenny Link, Dorothea Martin, View ORCID ProfileMalin Ryner, Christina Hermanrud, Verena Grummel, Michael Auer, Harald Hegen, View ORCID ProfileLilian Aly, Christiane Gasperi, Benjamin Knier, View ORCID ProfileBertram Müller-Myhsok, Poul Erik Hyldgaard Jensen, View ORCID ProfileFinn Sellebjerg, View ORCID ProfileIngrid Kockum, View ORCID ProfileTomas Olsson, Marc Pallardy, View ORCID ProfileSebastian Spindeldreher, View ORCID ProfileFlorian Deisenhammer, View ORCID ProfileAnna Fogdell-Hahn, View ORCID ProfileBernhard Hemmer on behalf of the ABIRISK consortium

doi: https://doi.org/10.1101/2020.05.01.20086033

Till F. M. Andlauer

1Department of Neurology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Ismaninger Str. 22, 81675 Munich, Germany

2Max Planck Institute of Psychiatry, Kraepelinstr. 2-10, 80804 Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Till F. M. Andlauer
For correspondence: hemmer{at}tum.de till.andlauer{at}tum.de

Jenny Link

3Department of Clinical Neuroscience, Karolinska Institutet, Visionsgatan 18, 17176 Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Jenny Link

Dorothea Martin

1Department of Neurology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Ismaninger Str. 22, 81675 Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Malin Ryner

3Department of Clinical Neuroscience, Karolinska Institutet, Visionsgatan 18, 17176 Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Malin Ryner

Christina Hermanrud

3Department of Clinical Neuroscience, Karolinska Institutet, Visionsgatan 18, 17176 Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Verena Grummel

1Department of Neurology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Ismaninger Str. 22, 81675 Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael Auer

4Department of Neurology, Medical University of Innsbruck, Anichstr. 35, 6020 Innsbruck, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Harald Hegen

4Department of Neurology, Medical University of Innsbruck, Anichstr. 35, 6020 Innsbruck, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lilian Aly

1Department of Neurology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Ismaninger Str. 22, 81675 Munich, Germany

5Institute of Experimental Neuroimmunology, Technical University of Munich, Trogerstr. 9, 81675 Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Lilian Aly

Christiane Gasperi

1Department of Neurology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Ismaninger Str. 22, 81675 Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Benjamin Knier

1Department of Neurology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Ismaninger Str. 22, 81675 Munich, Germany

5Institute of Experimental Neuroimmunology, Technical University of Munich, Trogerstr. 9, 81675 Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Bertram Müller-Myhsok

2Max Planck Institute of Psychiatry, Kraepelinstr. 2-10, 80804 Munich, Germany

6Institute of Translational Medicine, University of Liverpool, Crown Street, Liverpool, L69 3BX, United Kingdom

7Munich Cluster for Systems Neurology (SyNergy), Feodor-Lynen-Str. 17, 81377 Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Bertram Müller-Myhsok

Poul Erik Hyldgaard Jensen

8DMSC, Department of Neurology, Rigshospitalet, University of Copenhagen, 2100 Copenhagen, Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Finn Sellebjerg

8DMSC, Department of Neurology, Rigshospitalet, University of Copenhagen, 2100 Copenhagen, Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Finn Sellebjerg

Ingrid Kockum

3Department of Clinical Neuroscience, Karolinska Institutet, Visionsgatan 18, 17176 Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Ingrid Kockum

Tomas Olsson

3Department of Clinical Neuroscience, Karolinska Institutet, Visionsgatan 18, 17176 Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Tomas Olsson

Marc Pallardy

9Inflammation, Microbiome and Immunosurveillance, Université Paris-Saclay, INSERM, Faculté de Pharmacie, rue JB Clément, 92290 Châtenay-Malabry, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sebastian Spindeldreher

10Novartis Institutes for Biomedical Research, Novartis Pharma AG, 4056 Basel, Switzerland

11Integrated Biologix GmbH, Steinenvorstadt 33, 4051 Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Sebastian Spindeldreher

Florian Deisenhammer

4Department of Neurology, Medical University of Innsbruck, Anichstr. 35, 6020 Innsbruck, Austria

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Florian Deisenhammer

Anna Fogdell-Hahn

3Department of Clinical Neuroscience, Karolinska Institutet, Visionsgatan 18, 17176 Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Anna Fogdell-Hahn

Bernhard Hemmer

1Department of Neurology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Ismaninger Str. 22, 81675 Munich, Germany

7Munich Cluster for Systems Neurology (SyNergy), Feodor-Lynen-Str. 17, 81377 Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Bernhard Hemmer
For correspondence: hemmer{at}tum.de till.andlauer{at}tum.de

Abstract
Full Text
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Data Availability

The datasets generated and analyzed during the current study are available from the corresponding authors on reasonable request.

View the discussion thread.

PreviousNext

Posted May 05, 2020.

Download PDF

Supplementary Material

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta

Till F. M. Andlauer, Jenny Link, Dorothea Martin, Malin Ryner, Christina Hermanrud, Verena Grummel, Michael Auer, Harald Hegen, Lilian Aly, Christiane Gasperi, Benjamin Knier, Bertram Müller-Myhsok, Poul Erik Hyldgaard Jensen, Finn Sellebjerg, Ingrid Kockum, Tomas Olsson, Marc Pallardy, Sebastian Spindeldreher, Florian Deisenhammer, Anna Fogdell-Hahn, Bernhard Hemmer

medRxiv 2020.05.01.20086033; doi: https://doi.org/10.1101/2020.05.01.20086033

Share This Article: